Back to mobile site
Get it on Google Play

Armata Pharmaceuticals receives FDA fast track status for AP-SA02

May 7, 2026 7:00 AM EDT Send to a Friend
Armata Pharmaceuticals, Inc. (NYSE American: ARMP) announced that the U.S. Food and Drug Administration has granted Fast Track Designation to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login